Translational Medicine in Improving Endometriosis Researches

In: Journal of International Obstetrics and Gynecology · 2011 · W2356653935
article OA: closed CC0
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-12

Translational medicine advances endometriosis research by integrating endometrial, stem cell, and archimetra insights for improved diagnosis, therapy, and prevention.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis(EMs) typically affects women of reproductive age.The underlining mechanisms of EM are not fully disclosed and treatment regimens do not provide satisfactory effects.Eutopic endometrium,stem cells and archimetra have been highly recognized in explaining the development of endometriosis,which also have great contributions to disease diagnosis,therapy development and preventive measures both theoretically and practically.New concepts such assource of diagnosingandsource of healingare introduced into diagnosis and management of EM,epidemiology researches are possible with the help of bioassays,these all suggest an important role of translational medicine in optimizing EM researches.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK